TY  - JOUR
AU  - Saei, Ali Kian
AU  - Asghari, Narjes
AU  - Jahangiri, Babak
AU  - Cordani, Marco
AU  - Nayeri, Zahra
AU  - Fard, Najaf Allahyari
AU  - Djavaheri-Mergny, Mojgan
AU  - Moosavi, Mohammad Amin
PY  - 2025
DO  - 10.1016/j.compbiomed.2025.109757
SN  - 0010-4825
UR  - https://hdl.handle.net/20.500.14352/119186
T2  - Computers in Biology and Medicine
AB  - Cancer treatment is often confounded by development of resistance to chemotherapy. This research explores the complex relationship between p62 (also known as SQSTM1), a multifunctional protein central in cancer signaling pathways — especially the...
LA  - eng
M2  - 1
PB  - Elsevier
KW  - Cancer therapeutics
KW  - Chemoresistance
KW  - Drug repositioning
KW  - NF-κB pathway
KW  - p62/SQSTM1
KW  - RIP1
KW  - ZZ domain
KW  - Bioinformatics
TI  - Drug repositioning and experimental validation for targeting ZZ domain of p62 as a cancer treatment
TY  - journal article
VL  - 188
ER  -